enzalutamide
pfizer,astellas
['enzamet', 'prostate']
prostate cancer research: #enzamet study shows enzalutamide + testosterone suppression (ts) improves overall survival compared to non-steroidal anti-androgen therapy + ts, with &gt; 5 years follow-up. dana-farber's senior author. #asco22
cc: 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090